Medical Care
Global Peptide Therapeutics Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
- Apr 16, 25
- ID: 189361
- Pages: 97
- Figures: 97
- Views: 1
The global Peptide Therapeutics market size was US$ 41000 million in 2024 and is forecast to a readjusted size of US$ 74320 million by 2031 with a CAGR of 9.0% during the forecast period 2025-2031.
Peptides are short chains of amino acid monomers linked by peptide (amide) bonds, the covalent chemical bonds formed when the carboxyl group of one amino acid reacts with the amino group of another.
Global Peptide Therapeutics key players include Sanofi, Novo Nordisk, Takeda, Eli Lilly, Ipsen, etc. Global top five manufacturers hold a share about 65%.
North America is the largest market, with a share about 55%, followed by Europe and Asia-Pacific, both have a share about 40 percent.
In terms of product, Injection is the largest segment, with a share about 70%. And in terms of application, the largest application is Cancer, followed by Central Nervous System.
The global Peptide Therapeutics market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
Sanofi
Teva
Novo Nordisk
Takeda
Eli Lilly
AstraZeneca
Novartis
AbbVie
Ipsen
Ferring
Merck
The Medicines
J & J
By Type: (Dominant Segment vs High-Margin Innovation)
Injection
Oral
Other
By Application: (Core Demand Driver vs Emerging Opportunity)
Cancer
Metabolic Disorders
Central Nervous System
Other
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Sanofi in Europe)
- Emerging Product Trends: Injection adoption vs. Oral premiumization
- Demand-Side Dynamics: Cancer growth in China vs. Metabolic Disorders potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
India
South America
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Peptide Therapeutics market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Oral in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Metabolic Disorders in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Peptide Therapeutics value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
Peptides are short chains of amino acid monomers linked by peptide (amide) bonds, the covalent chemical bonds formed when the carboxyl group of one amino acid reacts with the amino group of another.
Global Peptide Therapeutics key players include Sanofi, Novo Nordisk, Takeda, Eli Lilly, Ipsen, etc. Global top five manufacturers hold a share about 65%.
North America is the largest market, with a share about 55%, followed by Europe and Asia-Pacific, both have a share about 40 percent.
In terms of product, Injection is the largest segment, with a share about 70%. And in terms of application, the largest application is Cancer, followed by Central Nervous System.
The global Peptide Therapeutics market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
Sanofi
Teva
Novo Nordisk
Takeda
Eli Lilly
AstraZeneca
Novartis
AbbVie
Ipsen
Ferring
Merck
The Medicines
J & J
By Type: (Dominant Segment vs High-Margin Innovation)
Injection
Oral
Other
By Application: (Core Demand Driver vs Emerging Opportunity)
Cancer
Metabolic Disorders
Central Nervous System
Other
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Sanofi in Europe)
- Emerging Product Trends: Injection adoption vs. Oral premiumization
- Demand-Side Dynamics: Cancer growth in China vs. Metabolic Disorders potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
India
South America
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Peptide Therapeutics market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Oral in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Metabolic Disorders in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Peptide Therapeutics value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Injection
1.2.3 Oral
1.2.4 Other
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Cancer
1.3.3 Metabolic Disorders
1.3.4 Central Nervous System
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Peptide Therapeutics Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Peptide Therapeutics Revenue Market Share by Region (2020-2025)
2.4 Global Peptide Therapeutics Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Peptide Therapeutics Market Size and Prospective (2020-2031)
2.5.2 Europe Peptide Therapeutics Market Size and Prospective (2020-2031)
2.5.3 China Peptide Therapeutics Market Size and Prospective (2020-2031)
2.5.4 Japan Peptide Therapeutics Market Size and Prospective (2020-2031)
2.5.5 India Peptide Therapeutics Market Size and Prospective (2020-2031)
2.5.6 South America Peptide Therapeutics Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Peptide Therapeutics Historic Market Size by Type (2020-2025)
3.2 Global Peptide Therapeutics Forecasted Market Size by Type (2026-2031)
3.3 Different Types Peptide Therapeutics Representative Players
4 Breakdown Data by Application
4.1 Global Peptide Therapeutics Historic Market Size by Application (2020-2025)
4.2 Global Peptide Therapeutics Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Peptide Therapeutics Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Peptide Therapeutics Players by Revenue (2020-2025)
5.1.2 Global Peptide Therapeutics Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Peptide Therapeutics Revenue
5.4 Global Peptide Therapeutics Market Concentration Analysis
5.4.1 Global Peptide Therapeutics Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Peptide Therapeutics Revenue in 2024
5.5 Global Key Players of Peptide Therapeutics Head office and Area Served
5.6 Global Key Players of Peptide Therapeutics, Product and Application
5.7 Global Key Players of Peptide Therapeutics, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Peptide Therapeutics Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Peptide Therapeutics Market Size by Type (2020-2025)
6.1.2.2 North America Peptide Therapeutics Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Peptide Therapeutics Market Size by Application (2020-2025)
6.1.3.2 North America Peptide Therapeutics Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Peptide Therapeutics Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Peptide Therapeutics Market Size by Type (2020-2025)
6.2.2.2 Europe Peptide Therapeutics Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Peptide Therapeutics Market Size by Application (2020-2025)
6.2.3.2 Europe Peptide Therapeutics Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments and Downstream
6.3.1 China Peptide Therapeutics Revenue by Company (2020-2025)
6.3.2 China Market Size by Type
6.3.2.1 China Peptide Therapeutics Market Size by Type (2020-2025)
6.3.2.2 China Peptide Therapeutics Market Share by Type (2020-2025)
6.3.3 China Market Size by Application
6.3.3.1 China Peptide Therapeutics Market Size by Application (2020-2025)
6.3.3.2 China Peptide Therapeutics Market Share by Application (2020-2025)
6.3.4 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments and Downstream
6.4.1 Japan Peptide Therapeutics Revenue by Company (2020-2025)
6.4.2 Japan Market Size by Type
6.4.2.1 Japan Peptide Therapeutics Market Size by Type (2020-2025)
6.4.2.2 Japan Peptide Therapeutics Market Share by Type (2020-2025)
6.4.3 Japan Market Size by Application
6.4.3.1 Japan Peptide Therapeutics Market Size by Application (2020-2025)
6.4.3.2 Japan Peptide Therapeutics Market Share by Application (2020-2025)
6.4.4 Japan Market Trend and Opportunities
6.5 India Market: Players, Segments and Downstream
6.5.1 India Peptide Therapeutics Revenue by Company (2020-2025)
6.5.2 India Market Size by Type
6.5.2.1 India Peptide Therapeutics Market Size by Type (2020-2025)
6.5.2.2 India Peptide Therapeutics Market Share by Type (2020-2025)
6.5.3 India Market Size by Application
6.5.3.1 India Peptide Therapeutics Market Size by Application (2020-2025)
6.5.3.2 India Peptide Therapeutics Market Share by Application (2020-2025)
6.5.4 India Market Trend and Opportunities
6.6 South America Market: Players, Segments and Downstream
6.6.1 South America Peptide Therapeutics Revenue by Company (2020-2025)
6.6.2 South America Market Size by Type
6.6.2.1 South America Peptide Therapeutics Market Size by Type (2020-2025)
6.6.2.2 South America Peptide Therapeutics Market Share by Type (2020-2025)
6.6.3 South America Market Size by Application
6.6.3.1 South America Peptide Therapeutics Market Size by Application (2020-2025)
6.6.3.2 South America Peptide Therapeutics Market Share by Application (2020-2025)
6.6.4 South America Market Trend and Opportunities
7 Key Players Profiles
7.1 Sanofi
7.1.1 Sanofi Company Details
7.1.2 Sanofi Business Overview
7.1.3 Sanofi Peptide Therapeutics Introduction
7.1.4 Sanofi Revenue in Peptide Therapeutics Business (2020-2025)
7.1.5 Sanofi Recent Development
7.2 Teva
7.2.1 Teva Company Details
7.2.2 Teva Business Overview
7.2.3 Teva Peptide Therapeutics Introduction
7.2.4 Teva Revenue in Peptide Therapeutics Business (2020-2025)
7.2.5 Teva Recent Development
7.3 Novo Nordisk
7.3.1 Novo Nordisk Company Details
7.3.2 Novo Nordisk Business Overview
7.3.3 Novo Nordisk Peptide Therapeutics Introduction
7.3.4 Novo Nordisk Revenue in Peptide Therapeutics Business (2020-2025)
7.3.5 Novo Nordisk Recent Development
7.4 Takeda
7.4.1 Takeda Company Details
7.4.2 Takeda Business Overview
7.4.3 Takeda Peptide Therapeutics Introduction
7.4.4 Takeda Revenue in Peptide Therapeutics Business (2020-2025)
7.4.5 Takeda Recent Development
7.5 Eli Lilly
7.5.1 Eli Lilly Company Details
7.5.2 Eli Lilly Business Overview
7.5.3 Eli Lilly Peptide Therapeutics Introduction
7.5.4 Eli Lilly Revenue in Peptide Therapeutics Business (2020-2025)
7.5.5 Eli Lilly Recent Development
7.6 AstraZeneca
7.6.1 AstraZeneca Company Details
7.6.2 AstraZeneca Business Overview
7.6.3 AstraZeneca Peptide Therapeutics Introduction
7.6.4 AstraZeneca Revenue in Peptide Therapeutics Business (2020-2025)
7.6.5 AstraZeneca Recent Development
7.7 Novartis
7.7.1 Novartis Company Details
7.7.2 Novartis Business Overview
7.7.3 Novartis Peptide Therapeutics Introduction
7.7.4 Novartis Revenue in Peptide Therapeutics Business (2020-2025)
7.7.5 Novartis Recent Development
7.8 AbbVie
7.8.1 AbbVie Company Details
7.8.2 AbbVie Business Overview
7.8.3 AbbVie Peptide Therapeutics Introduction
7.8.4 AbbVie Revenue in Peptide Therapeutics Business (2020-2025)
7.8.5 AbbVie Recent Development
7.9 Ipsen
7.9.1 Ipsen Company Details
7.9.2 Ipsen Business Overview
7.9.3 Ipsen Peptide Therapeutics Introduction
7.9.4 Ipsen Revenue in Peptide Therapeutics Business (2020-2025)
7.9.5 Ipsen Recent Development
7.10 Ferring
7.10.1 Ferring Company Details
7.10.2 Ferring Business Overview
7.10.3 Ferring Peptide Therapeutics Introduction
7.10.4 Ferring Revenue in Peptide Therapeutics Business (2020-2025)
7.10.5 Ferring Recent Development
7.11 Merck
7.11.1 Merck Company Details
7.11.2 Merck Business Overview
7.11.3 Merck Peptide Therapeutics Introduction
7.11.4 Merck Revenue in Peptide Therapeutics Business (2020-2025)
7.11.5 Merck Recent Development
7.12 The Medicines
7.12.1 The Medicines Company Details
7.12.2 The Medicines Business Overview
7.12.3 The Medicines Peptide Therapeutics Introduction
7.12.4 The Medicines Revenue in Peptide Therapeutics Business (2020-2025)
7.12.5 The Medicines Recent Development
7.13 J & J
7.13.1 J & J Company Details
7.13.2 J & J Business Overview
7.13.3 J & J Peptide Therapeutics Introduction
7.13.4 J & J Revenue in Peptide Therapeutics Business (2020-2025)
7.13.5 J & J Recent Development
8 Peptide Therapeutics Market Dynamics
8.1 Peptide Therapeutics Industry Trends
8.2 Peptide Therapeutics Market Drivers
8.3 Peptide Therapeutics Market Challenges
8.4 Peptide Therapeutics Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Injection
1.2.3 Oral
1.2.4 Other
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Cancer
1.3.3 Metabolic Disorders
1.3.4 Central Nervous System
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Peptide Therapeutics Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Peptide Therapeutics Revenue Market Share by Region (2020-2025)
2.4 Global Peptide Therapeutics Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Peptide Therapeutics Market Size and Prospective (2020-2031)
2.5.2 Europe Peptide Therapeutics Market Size and Prospective (2020-2031)
2.5.3 China Peptide Therapeutics Market Size and Prospective (2020-2031)
2.5.4 Japan Peptide Therapeutics Market Size and Prospective (2020-2031)
2.5.5 India Peptide Therapeutics Market Size and Prospective (2020-2031)
2.5.6 South America Peptide Therapeutics Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Peptide Therapeutics Historic Market Size by Type (2020-2025)
3.2 Global Peptide Therapeutics Forecasted Market Size by Type (2026-2031)
3.3 Different Types Peptide Therapeutics Representative Players
4 Breakdown Data by Application
4.1 Global Peptide Therapeutics Historic Market Size by Application (2020-2025)
4.2 Global Peptide Therapeutics Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Peptide Therapeutics Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Peptide Therapeutics Players by Revenue (2020-2025)
5.1.2 Global Peptide Therapeutics Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Peptide Therapeutics Revenue
5.4 Global Peptide Therapeutics Market Concentration Analysis
5.4.1 Global Peptide Therapeutics Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Peptide Therapeutics Revenue in 2024
5.5 Global Key Players of Peptide Therapeutics Head office and Area Served
5.6 Global Key Players of Peptide Therapeutics, Product and Application
5.7 Global Key Players of Peptide Therapeutics, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Peptide Therapeutics Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Peptide Therapeutics Market Size by Type (2020-2025)
6.1.2.2 North America Peptide Therapeutics Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Peptide Therapeutics Market Size by Application (2020-2025)
6.1.3.2 North America Peptide Therapeutics Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Peptide Therapeutics Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Peptide Therapeutics Market Size by Type (2020-2025)
6.2.2.2 Europe Peptide Therapeutics Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Peptide Therapeutics Market Size by Application (2020-2025)
6.2.3.2 Europe Peptide Therapeutics Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments and Downstream
6.3.1 China Peptide Therapeutics Revenue by Company (2020-2025)
6.3.2 China Market Size by Type
6.3.2.1 China Peptide Therapeutics Market Size by Type (2020-2025)
6.3.2.2 China Peptide Therapeutics Market Share by Type (2020-2025)
6.3.3 China Market Size by Application
6.3.3.1 China Peptide Therapeutics Market Size by Application (2020-2025)
6.3.3.2 China Peptide Therapeutics Market Share by Application (2020-2025)
6.3.4 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments and Downstream
6.4.1 Japan Peptide Therapeutics Revenue by Company (2020-2025)
6.4.2 Japan Market Size by Type
6.4.2.1 Japan Peptide Therapeutics Market Size by Type (2020-2025)
6.4.2.2 Japan Peptide Therapeutics Market Share by Type (2020-2025)
6.4.3 Japan Market Size by Application
6.4.3.1 Japan Peptide Therapeutics Market Size by Application (2020-2025)
6.4.3.2 Japan Peptide Therapeutics Market Share by Application (2020-2025)
6.4.4 Japan Market Trend and Opportunities
6.5 India Market: Players, Segments and Downstream
6.5.1 India Peptide Therapeutics Revenue by Company (2020-2025)
6.5.2 India Market Size by Type
6.5.2.1 India Peptide Therapeutics Market Size by Type (2020-2025)
6.5.2.2 India Peptide Therapeutics Market Share by Type (2020-2025)
6.5.3 India Market Size by Application
6.5.3.1 India Peptide Therapeutics Market Size by Application (2020-2025)
6.5.3.2 India Peptide Therapeutics Market Share by Application (2020-2025)
6.5.4 India Market Trend and Opportunities
6.6 South America Market: Players, Segments and Downstream
6.6.1 South America Peptide Therapeutics Revenue by Company (2020-2025)
6.6.2 South America Market Size by Type
6.6.2.1 South America Peptide Therapeutics Market Size by Type (2020-2025)
6.6.2.2 South America Peptide Therapeutics Market Share by Type (2020-2025)
6.6.3 South America Market Size by Application
6.6.3.1 South America Peptide Therapeutics Market Size by Application (2020-2025)
6.6.3.2 South America Peptide Therapeutics Market Share by Application (2020-2025)
6.6.4 South America Market Trend and Opportunities
7 Key Players Profiles
7.1 Sanofi
7.1.1 Sanofi Company Details
7.1.2 Sanofi Business Overview
7.1.3 Sanofi Peptide Therapeutics Introduction
7.1.4 Sanofi Revenue in Peptide Therapeutics Business (2020-2025)
7.1.5 Sanofi Recent Development
7.2 Teva
7.2.1 Teva Company Details
7.2.2 Teva Business Overview
7.2.3 Teva Peptide Therapeutics Introduction
7.2.4 Teva Revenue in Peptide Therapeutics Business (2020-2025)
7.2.5 Teva Recent Development
7.3 Novo Nordisk
7.3.1 Novo Nordisk Company Details
7.3.2 Novo Nordisk Business Overview
7.3.3 Novo Nordisk Peptide Therapeutics Introduction
7.3.4 Novo Nordisk Revenue in Peptide Therapeutics Business (2020-2025)
7.3.5 Novo Nordisk Recent Development
7.4 Takeda
7.4.1 Takeda Company Details
7.4.2 Takeda Business Overview
7.4.3 Takeda Peptide Therapeutics Introduction
7.4.4 Takeda Revenue in Peptide Therapeutics Business (2020-2025)
7.4.5 Takeda Recent Development
7.5 Eli Lilly
7.5.1 Eli Lilly Company Details
7.5.2 Eli Lilly Business Overview
7.5.3 Eli Lilly Peptide Therapeutics Introduction
7.5.4 Eli Lilly Revenue in Peptide Therapeutics Business (2020-2025)
7.5.5 Eli Lilly Recent Development
7.6 AstraZeneca
7.6.1 AstraZeneca Company Details
7.6.2 AstraZeneca Business Overview
7.6.3 AstraZeneca Peptide Therapeutics Introduction
7.6.4 AstraZeneca Revenue in Peptide Therapeutics Business (2020-2025)
7.6.5 AstraZeneca Recent Development
7.7 Novartis
7.7.1 Novartis Company Details
7.7.2 Novartis Business Overview
7.7.3 Novartis Peptide Therapeutics Introduction
7.7.4 Novartis Revenue in Peptide Therapeutics Business (2020-2025)
7.7.5 Novartis Recent Development
7.8 AbbVie
7.8.1 AbbVie Company Details
7.8.2 AbbVie Business Overview
7.8.3 AbbVie Peptide Therapeutics Introduction
7.8.4 AbbVie Revenue in Peptide Therapeutics Business (2020-2025)
7.8.5 AbbVie Recent Development
7.9 Ipsen
7.9.1 Ipsen Company Details
7.9.2 Ipsen Business Overview
7.9.3 Ipsen Peptide Therapeutics Introduction
7.9.4 Ipsen Revenue in Peptide Therapeutics Business (2020-2025)
7.9.5 Ipsen Recent Development
7.10 Ferring
7.10.1 Ferring Company Details
7.10.2 Ferring Business Overview
7.10.3 Ferring Peptide Therapeutics Introduction
7.10.4 Ferring Revenue in Peptide Therapeutics Business (2020-2025)
7.10.5 Ferring Recent Development
7.11 Merck
7.11.1 Merck Company Details
7.11.2 Merck Business Overview
7.11.3 Merck Peptide Therapeutics Introduction
7.11.4 Merck Revenue in Peptide Therapeutics Business (2020-2025)
7.11.5 Merck Recent Development
7.12 The Medicines
7.12.1 The Medicines Company Details
7.12.2 The Medicines Business Overview
7.12.3 The Medicines Peptide Therapeutics Introduction
7.12.4 The Medicines Revenue in Peptide Therapeutics Business (2020-2025)
7.12.5 The Medicines Recent Development
7.13 J & J
7.13.1 J & J Company Details
7.13.2 J & J Business Overview
7.13.3 J & J Peptide Therapeutics Introduction
7.13.4 J & J Revenue in Peptide Therapeutics Business (2020-2025)
7.13.5 J & J Recent Development
8 Peptide Therapeutics Market Dynamics
8.1 Peptide Therapeutics Industry Trends
8.2 Peptide Therapeutics Market Drivers
8.3 Peptide Therapeutics Market Challenges
8.4 Peptide Therapeutics Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Global Peptide Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Peptide Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market Peptide Therapeutics Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Peptide Therapeutics Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global Peptide Therapeutics Revenue Share by Region (2020-2025)
Table 6. Global Peptide Therapeutics Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global Peptide Therapeutics Revenue Share Forecast by Region (2026-2031)
Table 8. Global Peptide Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global Peptide Therapeutics Revenue Market Share by Type (2020-2025)
Table 10. Global Peptide Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global Peptide Therapeutics Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global Peptide Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global Peptide Therapeutics Revenue Market Share by Application (2020-2025)
Table 15. Global Peptide Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global Peptide Therapeutics Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in Peptide Therapeutics Application
Table 18. Global Peptide Therapeutics Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Peptide Therapeutics Market Share by Players (2020-2025)
Table 20. Global Top Peptide Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide Therapeutics as of 2024)
Table 21. Ranking of Global Top Peptide Therapeutics Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Peptide Therapeutics Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Peptide Therapeutics, Headquarters and Area Served
Table 24. Global Key Players of Peptide Therapeutics, Product and Application
Table 25. Global Key Players of Peptide Therapeutics, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Peptide Therapeutics Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America Peptide Therapeutics Revenue Market Share by Company (2020-2025)
Table 29. North America Peptide Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America Peptide Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe Peptide Therapeutics Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe Peptide Therapeutics Revenue Market Share by Company (2020-2025)
Table 33. Europe Peptide Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe Peptide Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 35. China Peptide Therapeutics Revenue by Company (2020-2025) & (US$ Million)
Table 36. China Peptide Therapeutics Revenue Market Share by Company (2020-2025)
Table 37. China Peptide Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 38. China Peptide Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 39. Japan Peptide Therapeutics Revenue by Company (2020-2025) & (US$ Million)
Table 40. Japan Peptide Therapeutics Revenue Market Share by Company (2020-2025)
Table 41. Japan Peptide Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 42. Japan Peptide Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 43. India Peptide Therapeutics Revenue by Company (2020-2025) & (US$ Million)
Table 44. India Peptide Therapeutics Revenue Market Share by Company (2020-2025)
Table 45. India Peptide Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 46. India Peptide Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 47. South America Peptide Therapeutics Revenue by Company (2020-2025) & (US$ Million)
Table 48. South America Peptide Therapeutics Revenue Market Share by Company (2020-2025)
Table 49. South America Peptide Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 50. South America Peptide Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 51. Sanofi Company Details
Table 52. Sanofi Business Overview
Table 53. Sanofi Peptide Therapeutics Product
Table 54. Sanofi Revenue in Peptide Therapeutics Business (2020-2025) & (US$ Million)
Table 55. Sanofi Recent Development
Table 56. Teva Company Details
Table 57. Teva Business Overview
Table 58. Teva Peptide Therapeutics Product
Table 59. Teva Revenue in Peptide Therapeutics Business (2020-2025) & (US$ Million)
Table 60. Teva Recent Development
Table 61. Novo Nordisk Company Details
Table 62. Novo Nordisk Business Overview
Table 63. Novo Nordisk Peptide Therapeutics Product
Table 64. Novo Nordisk Revenue in Peptide Therapeutics Business (2020-2025) & (US$ Million)
Table 65. Novo Nordisk Recent Development
Table 66. Takeda Company Details
Table 67. Takeda Business Overview
Table 68. Takeda Peptide Therapeutics Product
Table 69. Takeda Revenue in Peptide Therapeutics Business (2020-2025) & (US$ Million)
Table 70. Takeda Recent Development
Table 71. Eli Lilly Company Details
Table 72. Eli Lilly Business Overview
Table 73. Eli Lilly Peptide Therapeutics Product
Table 74. Eli Lilly Revenue in Peptide Therapeutics Business (2020-2025) & (US$ Million)
Table 75. Eli Lilly Recent Development
Table 76. AstraZeneca Company Details
Table 77. AstraZeneca Business Overview
Table 78. AstraZeneca Peptide Therapeutics Product
Table 79. AstraZeneca Revenue in Peptide Therapeutics Business (2020-2025) & (US$ Million)
Table 80. AstraZeneca Recent Development
Table 81. Novartis Company Details
Table 82. Novartis Business Overview
Table 83. Novartis Peptide Therapeutics Product
Table 84. Novartis Revenue in Peptide Therapeutics Business (2020-2025) & (US$ Million)
Table 85. Novartis Recent Development
Table 86. AbbVie Company Details
Table 87. AbbVie Business Overview
Table 88. AbbVie Peptide Therapeutics Product
Table 89. AbbVie Revenue in Peptide Therapeutics Business (2020-2025) & (US$ Million)
Table 90. AbbVie Recent Development
Table 91. Ipsen Company Details
Table 92. Ipsen Business Overview
Table 93. Ipsen Peptide Therapeutics Product
Table 94. Ipsen Revenue in Peptide Therapeutics Business (2020-2025) & (US$ Million)
Table 95. Ipsen Recent Development
Table 96. Ferring Company Details
Table 97. Ferring Business Overview
Table 98. Ferring Peptide Therapeutics Product
Table 99. Ferring Revenue in Peptide Therapeutics Business (2020-2025) & (US$ Million)
Table 100. Ferring Recent Development
Table 101. Merck Company Details
Table 102. Merck Business Overview
Table 103. Merck Peptide Therapeutics Product
Table 104. Merck Revenue in Peptide Therapeutics Business (2020-2025) & (US$ Million)
Table 105. Merck Recent Development
Table 106. The Medicines Company Details
Table 107. The Medicines Business Overview
Table 108. The Medicines Peptide Therapeutics Product
Table 109. The Medicines Revenue in Peptide Therapeutics Business (2020-2025) & (US$ Million)
Table 110. The Medicines Recent Development
Table 111. J & J Company Details
Table 112. J & J Business Overview
Table 113. J & J Peptide Therapeutics Product
Table 114. J & J Revenue in Peptide Therapeutics Business (2020-2025) & (US$ Million)
Table 115. J & J Recent Development
Table 116. Peptide Therapeutics Market Trends
Table 117. Peptide Therapeutics Market Drivers
Table 118. Peptide Therapeutics Market Challenges
Table 119. Peptide Therapeutics Market Restraints
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Peptide Therapeutics Product Picture
Figure 2. Global Peptide Therapeutics Market Share by Type: 2024 VS 2031
Figure 3. Injection Features
Figure 4. Oral Features
Figure 5. Other Features
Figure 6. Global Peptide Therapeutics Market Share by Application: 2024 VS 2031
Figure 7. Cancer
Figure 8. Metabolic Disorders
Figure 9. Central Nervous System
Figure 10. Other
Figure 11. Peptide Therapeutics Report Years Considered
Figure 12. Global Peptide Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Peptide Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Peptide Therapeutics Revenue Market Share by Region: 2020 VS 2024
Figure 15. North America Peptide Therapeutics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 16. Europe Peptide Therapeutics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 17. China Peptide Therapeutics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 18. Japan Peptide Therapeutics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 19. India Peptide Therapeutics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 20. South America Peptide Therapeutics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 21. Global Peptide Therapeutics Market Share by Players in 2024
Figure 22. Global Top Peptide Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide Therapeutics as of 2024)
Figure 23. The Top 10 and 5 Players Market Share by Peptide Therapeutics Revenue in 2024
Figure 24. North America Peptide Therapeutics Market Share by Type (2020-2025)
Figure 25. North America Peptide Therapeutics Market Share by Application (2020-2025)
Figure 26. Europe Peptide Therapeutics Market Share by Type (2020-2025)
Figure 27. Europe Peptide Therapeutics Market Share by Application (2020-2025)
Figure 28. China Peptide Therapeutics Market Share by Type (2020-2025)
Figure 29. China Peptide Therapeutics Market Share by Application (2020-2025)
Figure 30. Japan Peptide Therapeutics Market Share by Type (2020-2025)
Figure 31. Japan Peptide Therapeutics Market Share by Application (2020-2025)
Figure 32. India Peptide Therapeutics Market Share by Type (2020-2025)
Figure 33. India Peptide Therapeutics Market Share by Application (2020-2025)
Figure 34. South America Peptide Therapeutics Market Share by Type (2020-2025)
Figure 35. South America Peptide Therapeutics Market Share by Application (2020-2025)
Figure 36. Sanofi Revenue Growth Rate in Peptide Therapeutics Business (2020-2025)
Figure 37. Teva Revenue Growth Rate in Peptide Therapeutics Business (2020-2025)
Figure 38. Novo Nordisk Revenue Growth Rate in Peptide Therapeutics Business (2020-2025)
Figure 39. Takeda Revenue Growth Rate in Peptide Therapeutics Business (2020-2025)
Figure 40. Eli Lilly Revenue Growth Rate in Peptide Therapeutics Business (2020-2025)
Figure 41. AstraZeneca Revenue Growth Rate in Peptide Therapeutics Business (2020-2025)
Figure 42. Novartis Revenue Growth Rate in Peptide Therapeutics Business (2020-2025)
Figure 43. AbbVie Revenue Growth Rate in Peptide Therapeutics Business (2020-2025)
Figure 44. Ipsen Revenue Growth Rate in Peptide Therapeutics Business (2020-2025)
Figure 45. Ferring Revenue Growth Rate in Peptide Therapeutics Business (2020-2025)
Figure 46. Merck Revenue Growth Rate in Peptide Therapeutics Business (2020-2025)
Figure 47. The Medicines Revenue Growth Rate in Peptide Therapeutics Business (2020-2025)
Figure 48. J & J Revenue Growth Rate in Peptide Therapeutics Business (2020-2025)
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed
Table 1. Global Peptide Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Peptide Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market Peptide Therapeutics Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Peptide Therapeutics Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global Peptide Therapeutics Revenue Share by Region (2020-2025)
Table 6. Global Peptide Therapeutics Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global Peptide Therapeutics Revenue Share Forecast by Region (2026-2031)
Table 8. Global Peptide Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global Peptide Therapeutics Revenue Market Share by Type (2020-2025)
Table 10. Global Peptide Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global Peptide Therapeutics Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global Peptide Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global Peptide Therapeutics Revenue Market Share by Application (2020-2025)
Table 15. Global Peptide Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global Peptide Therapeutics Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in Peptide Therapeutics Application
Table 18. Global Peptide Therapeutics Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Peptide Therapeutics Market Share by Players (2020-2025)
Table 20. Global Top Peptide Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide Therapeutics as of 2024)
Table 21. Ranking of Global Top Peptide Therapeutics Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Peptide Therapeutics Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Peptide Therapeutics, Headquarters and Area Served
Table 24. Global Key Players of Peptide Therapeutics, Product and Application
Table 25. Global Key Players of Peptide Therapeutics, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Peptide Therapeutics Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America Peptide Therapeutics Revenue Market Share by Company (2020-2025)
Table 29. North America Peptide Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America Peptide Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe Peptide Therapeutics Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe Peptide Therapeutics Revenue Market Share by Company (2020-2025)
Table 33. Europe Peptide Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe Peptide Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 35. China Peptide Therapeutics Revenue by Company (2020-2025) & (US$ Million)
Table 36. China Peptide Therapeutics Revenue Market Share by Company (2020-2025)
Table 37. China Peptide Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 38. China Peptide Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 39. Japan Peptide Therapeutics Revenue by Company (2020-2025) & (US$ Million)
Table 40. Japan Peptide Therapeutics Revenue Market Share by Company (2020-2025)
Table 41. Japan Peptide Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 42. Japan Peptide Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 43. India Peptide Therapeutics Revenue by Company (2020-2025) & (US$ Million)
Table 44. India Peptide Therapeutics Revenue Market Share by Company (2020-2025)
Table 45. India Peptide Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 46. India Peptide Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 47. South America Peptide Therapeutics Revenue by Company (2020-2025) & (US$ Million)
Table 48. South America Peptide Therapeutics Revenue Market Share by Company (2020-2025)
Table 49. South America Peptide Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 50. South America Peptide Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 51. Sanofi Company Details
Table 52. Sanofi Business Overview
Table 53. Sanofi Peptide Therapeutics Product
Table 54. Sanofi Revenue in Peptide Therapeutics Business (2020-2025) & (US$ Million)
Table 55. Sanofi Recent Development
Table 56. Teva Company Details
Table 57. Teva Business Overview
Table 58. Teva Peptide Therapeutics Product
Table 59. Teva Revenue in Peptide Therapeutics Business (2020-2025) & (US$ Million)
Table 60. Teva Recent Development
Table 61. Novo Nordisk Company Details
Table 62. Novo Nordisk Business Overview
Table 63. Novo Nordisk Peptide Therapeutics Product
Table 64. Novo Nordisk Revenue in Peptide Therapeutics Business (2020-2025) & (US$ Million)
Table 65. Novo Nordisk Recent Development
Table 66. Takeda Company Details
Table 67. Takeda Business Overview
Table 68. Takeda Peptide Therapeutics Product
Table 69. Takeda Revenue in Peptide Therapeutics Business (2020-2025) & (US$ Million)
Table 70. Takeda Recent Development
Table 71. Eli Lilly Company Details
Table 72. Eli Lilly Business Overview
Table 73. Eli Lilly Peptide Therapeutics Product
Table 74. Eli Lilly Revenue in Peptide Therapeutics Business (2020-2025) & (US$ Million)
Table 75. Eli Lilly Recent Development
Table 76. AstraZeneca Company Details
Table 77. AstraZeneca Business Overview
Table 78. AstraZeneca Peptide Therapeutics Product
Table 79. AstraZeneca Revenue in Peptide Therapeutics Business (2020-2025) & (US$ Million)
Table 80. AstraZeneca Recent Development
Table 81. Novartis Company Details
Table 82. Novartis Business Overview
Table 83. Novartis Peptide Therapeutics Product
Table 84. Novartis Revenue in Peptide Therapeutics Business (2020-2025) & (US$ Million)
Table 85. Novartis Recent Development
Table 86. AbbVie Company Details
Table 87. AbbVie Business Overview
Table 88. AbbVie Peptide Therapeutics Product
Table 89. AbbVie Revenue in Peptide Therapeutics Business (2020-2025) & (US$ Million)
Table 90. AbbVie Recent Development
Table 91. Ipsen Company Details
Table 92. Ipsen Business Overview
Table 93. Ipsen Peptide Therapeutics Product
Table 94. Ipsen Revenue in Peptide Therapeutics Business (2020-2025) & (US$ Million)
Table 95. Ipsen Recent Development
Table 96. Ferring Company Details
Table 97. Ferring Business Overview
Table 98. Ferring Peptide Therapeutics Product
Table 99. Ferring Revenue in Peptide Therapeutics Business (2020-2025) & (US$ Million)
Table 100. Ferring Recent Development
Table 101. Merck Company Details
Table 102. Merck Business Overview
Table 103. Merck Peptide Therapeutics Product
Table 104. Merck Revenue in Peptide Therapeutics Business (2020-2025) & (US$ Million)
Table 105. Merck Recent Development
Table 106. The Medicines Company Details
Table 107. The Medicines Business Overview
Table 108. The Medicines Peptide Therapeutics Product
Table 109. The Medicines Revenue in Peptide Therapeutics Business (2020-2025) & (US$ Million)
Table 110. The Medicines Recent Development
Table 111. J & J Company Details
Table 112. J & J Business Overview
Table 113. J & J Peptide Therapeutics Product
Table 114. J & J Revenue in Peptide Therapeutics Business (2020-2025) & (US$ Million)
Table 115. J & J Recent Development
Table 116. Peptide Therapeutics Market Trends
Table 117. Peptide Therapeutics Market Drivers
Table 118. Peptide Therapeutics Market Challenges
Table 119. Peptide Therapeutics Market Restraints
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Peptide Therapeutics Product Picture
Figure 2. Global Peptide Therapeutics Market Share by Type: 2024 VS 2031
Figure 3. Injection Features
Figure 4. Oral Features
Figure 5. Other Features
Figure 6. Global Peptide Therapeutics Market Share by Application: 2024 VS 2031
Figure 7. Cancer
Figure 8. Metabolic Disorders
Figure 9. Central Nervous System
Figure 10. Other
Figure 11. Peptide Therapeutics Report Years Considered
Figure 12. Global Peptide Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Peptide Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Peptide Therapeutics Revenue Market Share by Region: 2020 VS 2024
Figure 15. North America Peptide Therapeutics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 16. Europe Peptide Therapeutics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 17. China Peptide Therapeutics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 18. Japan Peptide Therapeutics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 19. India Peptide Therapeutics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 20. South America Peptide Therapeutics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 21. Global Peptide Therapeutics Market Share by Players in 2024
Figure 22. Global Top Peptide Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide Therapeutics as of 2024)
Figure 23. The Top 10 and 5 Players Market Share by Peptide Therapeutics Revenue in 2024
Figure 24. North America Peptide Therapeutics Market Share by Type (2020-2025)
Figure 25. North America Peptide Therapeutics Market Share by Application (2020-2025)
Figure 26. Europe Peptide Therapeutics Market Share by Type (2020-2025)
Figure 27. Europe Peptide Therapeutics Market Share by Application (2020-2025)
Figure 28. China Peptide Therapeutics Market Share by Type (2020-2025)
Figure 29. China Peptide Therapeutics Market Share by Application (2020-2025)
Figure 30. Japan Peptide Therapeutics Market Share by Type (2020-2025)
Figure 31. Japan Peptide Therapeutics Market Share by Application (2020-2025)
Figure 32. India Peptide Therapeutics Market Share by Type (2020-2025)
Figure 33. India Peptide Therapeutics Market Share by Application (2020-2025)
Figure 34. South America Peptide Therapeutics Market Share by Type (2020-2025)
Figure 35. South America Peptide Therapeutics Market Share by Application (2020-2025)
Figure 36. Sanofi Revenue Growth Rate in Peptide Therapeutics Business (2020-2025)
Figure 37. Teva Revenue Growth Rate in Peptide Therapeutics Business (2020-2025)
Figure 38. Novo Nordisk Revenue Growth Rate in Peptide Therapeutics Business (2020-2025)
Figure 39. Takeda Revenue Growth Rate in Peptide Therapeutics Business (2020-2025)
Figure 40. Eli Lilly Revenue Growth Rate in Peptide Therapeutics Business (2020-2025)
Figure 41. AstraZeneca Revenue Growth Rate in Peptide Therapeutics Business (2020-2025)
Figure 42. Novartis Revenue Growth Rate in Peptide Therapeutics Business (2020-2025)
Figure 43. AbbVie Revenue Growth Rate in Peptide Therapeutics Business (2020-2025)
Figure 44. Ipsen Revenue Growth Rate in Peptide Therapeutics Business (2020-2025)
Figure 45. Ferring Revenue Growth Rate in Peptide Therapeutics Business (2020-2025)
Figure 46. Merck Revenue Growth Rate in Peptide Therapeutics Business (2020-2025)
Figure 47. The Medicines Revenue Growth Rate in Peptide Therapeutics Business (2020-2025)
Figure 48. J & J Revenue Growth Rate in Peptide Therapeutics Business (2020-2025)
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Coke Oven Inspection Intelligent Robot Market Research Report 2025
Apr 16, 25
Global Explosion-Proof Fire Extinguishing Reconnaissance Robot Market Research Report 2025
Apr 16, 25
Global Electric Wheeled Inspection Robot Market Research Report 2025
Apr 16, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232